September 28^th, 2020
AseBio Investor Day 2020 is a digital event from September 28th to October 1st, organized by the Spanish Association of Bioempresas (AseBio), together with the Biotechnology Market Platform (Ministry of Science), Innovation and Universities, the Institute of Foreign Trade (ICEX) and the BioVoices project.

PROALT will participate in the partnering event and will met during these days with several investors, pharma companies working in therapeutics and potential technological partners.

The company will present the latest advances of the lead therapeutic product hPA-0661 currently in pre-clinical phase, a humanized monoclonal antibody for the treatment of metastatic colorectal cancer.